TI - Prognostic Impact of RAS Mutation and Biologic Therapy in Second-Line Treatment of De-Novo Metastatic Colorectal Cancer: A Real-World Retrospective Analysis
PT - Journal Article
DP - 2026
TA - EJMI
PG - 385-391
VI - 10
IP - 3
AID - 269385 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.269385
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2026 10(3): 385